zubeen shroff.jpeg

Zubeen Shroff
Managing Director



phone: 203-653-6430
LinkedIn

Mr. Shroff is a Managing Partner of Galen Partners. With over twenty years of experience in building healthcare companies, Mr. Shroff has acquired deep expertise, and demonstrated strong leadership in working with entrepreneurs to maximize shareholder value in the areas of therapeutic devices, diagnostics, capital equipment, specialty supplies distribution, consumer driven healthcare, homecare based solutions and technology enabled services. Successful Galen portfolio companies in which Mr. Shroff played a key leadership role include: Acura Pharmaceuticals, Aperio, Cambrooke Medical Foods, Dow Pharmaceutical Sciences, Encore Medical, JDS Pharmaceuticals, Lumenos, MiniMed, National Rehab Equipment, Nautilus Neurosciences, and Tactile Systems.

Prior to joining Galen in 1997, Mr. Shroff was a Principal at The Wilkerson Group, a leading medical products management consulting firm, with a client base including pharmaceutical, diagnostic, device and biotech companies, as well as a few select venture capital firms. Mr. Shroff started his career at Schering-Plough Pharmaceuticals where he directed marketing, sales, and Phase IV clinical development for the company’s high growth biotech business in France and was responsible for the launch of alpha-Interferon in several new indications.

Mr. Shroff is Vice-Chairman for $800 million Westchester Medical Center Public Benefit Corporation, as well as Chairman of its Foundation. Since 2004, he has served on Advisory Committees to Boston University Medical School and The Center for Global Health and Development. Mr. Shroff is on the advisory board of the Joslin Diabetes Center. He is a frequent speaker on healthcare market trends, winning medical product and service business models, and the private equity investment climate.

Mr. Shroff earned an M.B.A. from the Wharton School and a B.A. in biological science from Boston University.

Mr. Shroff is a Managing Director of Galen Partners, a leading healthcare growth equity investment firm founded in 1990. With over 25 years of experience in building healthcare companies, Mr. Shroff has acquired deep expertise, and demonstrated strong leadership in working with entrepreneurs to maximize shareholder value in the following areas: specialty pharmaceuticals, medical imaging, therapeutic devices, diagnostics, capital equipment, specialty supplies distribution, consumer driven healthcare, insurance & payor services, homecare based solutions and technology enabled services. Successful Galen portfolio companies in which Mr. Shroff played a key leadership role include: Aperio Digital Pathology, Cambrooke Therapeutics, Dow Pharma Sciences, Encore Medical, International Medical Group, JDS Pharmaceuticals, Lumenos, MiniMed, National Rehab Equipment, Nautilus Pharmaceuticals, Quotient Biodiagnostics, and Tactile Medical Systems.

Prior to joining Galen in 1997, Mr. Shroff was a Principal at The Wilkerson Group, a leading medical products management consulting firm, with a client base including pharmaceutical, diagnostic, device and biotech companies, as well as a few select venture capital firms. He played a major role in developing several of The Wilkerson Group’s practice areas, including outcomes research, strategy formulation, and disease management initiatives. He is co-author of the book, Integrated Healthcare: Pharmaceutical Company Roles in a Seamless System of Patient Care. Mr. Shroff was a key member of the deal team that sold The Wilkerson Group to IBM Corporation. Mr. Shroff started his career at Schering-Plough Pharmaceuticals, where he directed marketing, sales, and Phase IV clinical development for the company’s high growth biotech business in France and was responsible for the launch of alpha-Interferon in several new indications.

Mr. Shroff serves as an advisor to several not-for-profit institutions.   He is Vice-Chairman for WMC Health, the $2 Billion healthcare system serving Hudson Valley New York residents, as well as, Chairman of its Charitable Foundation. Since 2004, he has served on Advisory Committees to Boston University Medical School and The B.U. School for Public Health.  Mr. Shroff is a frequent speaker on healthcare market trends, winning medical product and service business models, and the private equity investment climate.

Mr. Shroff earned an M.B.A. from the Wharton School and a B.A. in Biological Science from Boston University.